Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

PUREGON DIN 02242441

Status: Cancelled Post Market
Holder: MERCK CANADA INC
Molecule: FOLLITROPIN BETA

Health Canada record

Active ingredient(s)FOLLITROPIN BETA 100 UNIT
Dosage formSolution
RouteIntramuscular; Subcutaneous
ScheduleSCHEDULE D; PRESCRIPTION
ClassHuman
ATCG03GA06 FOLLITROPIN BETA
Original market date24-Oct-2001
Current status date31-Jul-2020
SourceHealth Canada DPD

Establishment licence of the holder

Merck Canada Inc — licence 101380, currently licensed, last inspection rating C (2023-07-17).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing FOLLITROPIN BETA

DINProductCompanyFormStrengthStatus
02243948PUREGONORGANON CANADA INC.SolutionFOLLITROPIN BETA 833 UNITMarketed
02242439PUREGONMERCK CANADA INCSolutionFOLLITROPIN BETA 50 UNITCancelled Post Market
02243949PUREGON (600 IU)ORGANON CANADA LTD LTEESolution; Powder For SolutionFOLLITROPIN BETA 737 UNITCancelled Post Market
02231656PUREGON 100 I.U.ORGANON CANADA LTD LTEELiquid; Powder For SolutionFOLLITROPIN BETA 100 UNIT; SODIUM CHLORIDE 1 MLCancelled Post Market
02231655PUREGON 50 I.U.ORGANON CANADA LTD LTEEPowder For Solution; LiquidFOLLITROPIN BETA 50 UNIT; SODIUM CHLORIDE 1 MLCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
122212011-03-25New Drug Submission (NDS)Manufacturer name change
100302009-02-04New Drug Submission (NDS)Manufacturer name change
11652000-06-13Supplement to a New Drug Submission (SNDS)NEW LIQUID FORMULATION AND THREE NEW STRENGTHS
Request a quote for PUREGON

How to read a Canadian DIN record